| # | Drug | Count |
|---|---|---|
| 0 | ESOMEPRAZOLE MAGNESIUM | 14 |
| 1 | ESOMEPRAZOLE | 8 |
| 2 | APIXABAN | 5 |
| 3 | PREDNISOLONE | 4 |
| 4 | PREDNISOLONE ORAL | 4 |
| 5 | PREDNISOLONE ORAL SOLUTION | 4 |
| 6 | ADALIMUMAB | 3 |
| 7 | ASPIRIN | 3 |
| 8 | ASPIRIN 325 MG | 3 |
| 9 | ASPIRIN 81 MG | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CABOTEGRAVIR SODIUM | 2 | 0.0012 |
| 1 | INSULIN DEGLUDEC AND LIRAGLUTIDE | 1 | 0.0006 |
| 2 | LOMUSTINE | 1 | 0.0004 |
| 3 | RILPIVIRINE | 2 | 0.0003 |
| 4 | AMLODIPINE AND ATORVASTATIN | 1 | 0.0002 |
| 5 | ALISKIREN HEMIFUMARATE | 1 | 0.0002 |
| 6 | MITOXANTRONE HYDROCHLORIDE | 1 | 0.0002 |
| 7 | GOLIMUMAB | 2 | 0.0002 |
| 8 | CABOTEGRAVIR AND RILPIVIRINE | 1 | 0.0002 |
| 9 | EDOXABAN TOSYLATE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 1 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 2 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 3 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 4 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Cholinesterase Inhibitor [EPC] | 1 | 0.0001 |
| 6 | beta3-Adrenergic Agonist [EPC] | 2 | 0.0000 |
| 7 | Histamine-2 Receptor Antagonist [EPC] | 4 | 0.0000 |
| 8 | General Anesthetic [EPC] | 1 | 0.0000 |
| 9 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1 | 0.0000 |